The mission of the Department of Cancer Biology is to build bridges and teams to drive the best ideas in basic and translational cancer biology and developmental therapeutics to achieve breakthrough advances in the prevention, treatment and cure of cancer.
The department faculty are international leaders in brain, colorectal and prostate cancers, leukemia and myeloma, as well as cancer stem cells, mechanisms of DNA damage and repair, and fundamental molecular and cellular processes that impact microbial infections and cancer. Identifying the molecular mechanisms involved in the development and progression of human cancers as well as in normal cellular regulatory processes is our goal, enabling us to achieve our long-term objective of rapidly translating research into strategies that improve patient outcomes.
The fellowship aims to nurture and develop early-career scientists.
The topical ointment uses the small molecule PALA, first developed to treat cancer 50 years ago.
The former chair of the Lerner Research Institute, George Stark, PhD, was celebrated with a day-long cancer symposium with talks from collaborators and colleagues on July 7.